| |||||||||||||||||||||
Welcome ! to the MHE Research Foundation website The MHE Research Foundation is a nonprofit 501(c)(3) organization dedicated to the support of, Researchers, Physicians and Families, Dealing with (MHE) Multiple Hereditary Exostoses Syndrome/(MO) Multiple Osteochondroma Syndrome a Rare Genetic Bone Disease. The MHE Research Foundations five point mission is to REACH, advance & support the following. |
| |||||||||||||||||||
| RESEARCH, to assist and support researchers in order to one day discover a treatment/cure for MHE/MO/HME. Our foundation works hand in hand with researchers from around the world in this mission. EDUCATION, to provide vital clinical informational guides benefiting both families and physicians. ADVOCACY, bring awareness about this rare neglected bone disease throughout the world. CLINICAL, to help provide resources to families enabling them to locate the medical care they require. HOPE, the research being conducted on MHE/MO/HME & the informational resources will bring a better quality of life to the families affected by this syndrome around the world. Scroll down to read highlights, use the tool bar section tabs above to view complete website information. |
Send us your comments, question & thoughts Click Here
Or email Boardofdirectors@mheresearchfoundation.org
Or email Boardofdirectors@mheresearchfoundation.org
This online registration forms has been encrypted with the following, SSL AES 256 bit encryption (High); RSA 1024 bit
exchange (Internet Security). Once you have registered, you can come back anytime to modify your profile.
When you register you will choose a password to log in.
Reminder to refresh your web-broswer as our websites is currently under reconstruction
exchange (Internet Security). Once you have registered, you can come back anytime to modify your profile.
When you register you will choose a password to log in.
Reminder to refresh your web-broswer as our websites is currently under reconstruction
|
The MHERF website has a language translations section, you can find all website pages that have been encoded for translation
into German, Chinese, Japanese, Korean, Arabic, French, Portuguese, Spanish and Italian languages.
into German, Chinese, Japanese, Korean, Arabic, French, Portuguese, Spanish and Italian languages.
| General donations to our foundation can be made Monthly,Quarterly,Annually as well as one time donation |
All donations made to the MHE Research Foundation are exempt from Federal Income Taxes under Section 501(c)(3) of the
Internal Revenue Code and are greatly appreciated. All donations go to help this foundation in its efforts to the further
understanding of MHE through research and education.
Internal Revenue Code and are greatly appreciated. All donations go to help this foundation in its efforts to the further
understanding of MHE through research and education.
| Make A Donation Via Check |
or
| The AWARENESS ribbon color for MHE/ MO /HME is WHITE. Please show your support for our cause by wearing a white ribbon this way when people ask! You can let them know what our ribbon means. |
| CONNECTION CORNER MHE FAMILY SUPPORT SECTION VIEW CLICK HERE |
http://www.limblengtheningdoc.org
http://www.lengthening.us/index.html
http://www.lengthening.us
http://www.stmarysmc.com/en-US/ourServices/medicalServices/Pages/PaleyAdvancedLimbLengtheningI
nstitute.aspx
http://www.lengthening.us/index.html
http://www.lengthening.us
http://www.stmarysmc.com/en-US/ourServices/medicalServices/Pages/PaleyAdvancedLimbLengtheningI
nstitute.aspx
Written consent must be obtained to attach web pages or the files attached to this website, please email the webmaster. Email the webmaster: webmaster@mheresearchfoundation.org Materials on this website are protected by copyright Copyright © 2014 The MHE Research Foundation Disclaimer: While many find the information useful, it is in no way a substitute for professional medical care. The information provided here is for educational and informational purposes only. This website does not engage in the practice of medicine. In all cases we recommend that you consult your own physician regarding any course of treatment or medicine. This web page was updated last on 3/16/14 12:0O pm Eastern time |
The MHE Research Foundation, we comply with the HONcode standard for health trust worthy information: By the Health On the Net Foundation.
Click here to verify.# HON Conduct 282463 and is the patient support link on the US Government Genetics Home Reference (http://ghr.nlm.nih.gov)
website, also linked for Patient Information on The Diseases Database a cross-referenced index of human disease, as well as the
Intute: health & life sciences a free online service providing access to the very best Web resources for education and research located in the UK
Click here to verify.# HON Conduct 282463 and is the patient support link on the US Government Genetics Home Reference (http://ghr.nlm.nih.gov)
website, also linked for Patient Information on The Diseases Database a cross-referenced index of human disease, as well as the
Intute: health & life sciences a free online service providing access to the very best Web resources for education and research located in the UK
| This website is regularly reviewed by members of the Scientific and Medical Advisory Board of the MHE Research Foundation. All online submission forms use (SSL AES 256 bit encryption (High); RSA 1024 bit exchange) Protocol with Privacy protection. Our goal is to make this website as safe and user friendly as possible. |
| The MHE Research Foundation is a participating member organization of the United States Bone and Joint Decade/Initiative, (USBJD/I) , USBJD/I Rare Bone Disease Patient Network , NBHA National Bone Health Alliance |
The MHE Research Foundation is proud to be an affiliate of the Society For Glycobiology
| What is Multiple Hereditary Exostoses Syndrome? Multiple Hereditary Exostoses (MHE) also often referred to as Hereditary Multiple Exostoses (HME) Multiple Osteochondromas (MO) is the preferred term used by the World Health Organization "WHO". |
| Research "PATIENT" Registry Click Here ** MHE / MO / HME Research Project is OPEN and needs patient participation.** Click Here |
| RESEARCH & THE SANFORD-BURNHAM |
Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
Jones KB1, Pacifici M, Hilton MJ. Connect Tissue Res. 2014 Apr;55(2):80-8. doi: 10.3109/03008207.2013.867957. Epub 2014 Feb 12.
To read this pull text publication click here
Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: A mechanism likely
deranged in Hereditary Multiple Exostoses.
Huegel J, Mundy C, Sgariglia F, Nygren P, Billings PC, Yamaguchi Y, Koyama E, Pacifici M.
Dev Biol. 2013 Feb 28. pii: S0012-1606(13)00087-0. doi: 10.1016/j.ydbio.2013.02.008.
Validation of a new multiple osteochondromas classification through Switching Neural Networks.
Mordenti M, Ferrari E, Pedrini E, Fabbri N, Campanacci L, Muselli M, Sangiorgi L.
Am J Med Genet A. 2013 Mar;161(3):556-60. doi: 10.1002/ajmg.a.35819. Epub 2013 Feb 8.
Loss of β-Catenin Induces Multifocal Periosteal Chondroma-Like Masses in Mice.
Cantley L, Saunders C, Guttenberg M, Candela ME, Ohta Y, Yasuhara R, Kondo N, Sgariglia F, Asai S, Zhang X, Qin L, Hecht JT, Chen D,
Yamamoto M, Toyosawa S, Dormans JP, Esko JD, Yamaguchi Y, Iwamoto M, Pacifici M, Enomoto-Iwamoto M.
Am J Pathol. 2013 Mar;182(3):917-27. doi: 10.1016/j.ajpath.2012.11.012.
Multiple Hereditary Exostoses: Its Burden on Childhood and Beyond: Commentary on an article by A.L. Goud, MD, et al.:
“Pain, Physical and Social Functioning, and Quality of Life in Individuals with Multiple Hereditary Exostoses in the Netherlands. A
National Cohort Study”. Arkader A.
J Bone Joint Surg Am. 2012 Jun 6;94(11):e811-1
To read this full text publication Click here
Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate.
Irie F, Badie-Mahdavi H, Yamaguchi Y.
Proc Natl Acad Sci U S A. 2012 Mar 12.
HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas.
Wiweger MI, Zhao Z, van Merkesteyn RJ, Roehl HH, Hogendoorn PC.
PLoS One. 2012;7(1):e29734. Epub 2012 Jan 11.
To read this full text publication Click here
Epiphyseal growth plate and secondary peripheral chondrosarcoma the neighbours matter.
J Pathol. 2012 Jan;226(2):219-28. doi: 10.1002/path.3003. Epub 2011 Nov 23.
de Andrea CE, Hogendoorn PC.
To read this full text publication Click here
Jones KB1, Pacifici M, Hilton MJ. Connect Tissue Res. 2014 Apr;55(2):80-8. doi: 10.3109/03008207.2013.867957. Epub 2014 Feb 12.
To read this pull text publication click here
Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: A mechanism likely
deranged in Hereditary Multiple Exostoses.
Huegel J, Mundy C, Sgariglia F, Nygren P, Billings PC, Yamaguchi Y, Koyama E, Pacifici M.
Dev Biol. 2013 Feb 28. pii: S0012-1606(13)00087-0. doi: 10.1016/j.ydbio.2013.02.008.
Validation of a new multiple osteochondromas classification through Switching Neural Networks.
Mordenti M, Ferrari E, Pedrini E, Fabbri N, Campanacci L, Muselli M, Sangiorgi L.
Am J Med Genet A. 2013 Mar;161(3):556-60. doi: 10.1002/ajmg.a.35819. Epub 2013 Feb 8.
Loss of β-Catenin Induces Multifocal Periosteal Chondroma-Like Masses in Mice.
Cantley L, Saunders C, Guttenberg M, Candela ME, Ohta Y, Yasuhara R, Kondo N, Sgariglia F, Asai S, Zhang X, Qin L, Hecht JT, Chen D,
Yamamoto M, Toyosawa S, Dormans JP, Esko JD, Yamaguchi Y, Iwamoto M, Pacifici M, Enomoto-Iwamoto M.
Am J Pathol. 2013 Mar;182(3):917-27. doi: 10.1016/j.ajpath.2012.11.012.
Multiple Hereditary Exostoses: Its Burden on Childhood and Beyond: Commentary on an article by A.L. Goud, MD, et al.:
“Pain, Physical and Social Functioning, and Quality of Life in Individuals with Multiple Hereditary Exostoses in the Netherlands. A
National Cohort Study”. Arkader A.
J Bone Joint Surg Am. 2012 Jun 6;94(11):e811-1
To read this full text publication Click here
Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate.
Irie F, Badie-Mahdavi H, Yamaguchi Y.
Proc Natl Acad Sci U S A. 2012 Mar 12.
HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas.
Wiweger MI, Zhao Z, van Merkesteyn RJ, Roehl HH, Hogendoorn PC.
PLoS One. 2012;7(1):e29734. Epub 2012 Jan 11.
To read this full text publication Click here
Epiphyseal growth plate and secondary peripheral chondrosarcoma the neighbours matter.
J Pathol. 2012 Jan;226(2):219-28. doi: 10.1002/path.3003. Epub 2011 Nov 23.
de Andrea CE, Hogendoorn PC.
To read this full text publication Click here
Selected Publications for full listing Click here
Yu Yamaguchi's research on "MHE" reveals new insights into autism, these findings also provide new insights for
the general autistic population Click here to read the extensive press release
the general autistic population Click here to read the extensive press release
| Journal "The Scientist" Bones to Brains - Autism- Relevant Behavioral Phenotype Click here to read this article PRESS RELEASE RESEARCH & THE SANFORD BURNHAM |
MHE / MO / HME is a genetic bone disorder in which benign cartilage-capped bone tumors grow outward from the metaphyses of
long bones, growth plates or from the surface of flat bones throughout the body. The severity of this disease varies widely.
Some patients may have as few as two tumors, but most patients develop many more and the numbers of tumors can run into
the hundreds.
These cartilage-capped bone tumors are called Exostoses / Osteochondroma and may be sessile or pedunculated and vary
widely in size and shape. Pedunculated Exostoses / Osteochondroma is when a stalk is present, the structure is called
pedunculated. These have a Broccoli like appearance with stalk and growth towards the end of the stalk. Sessile Exostoses /
Osteochondroma have a broad-base attachment to the outer bone, called the "cortex". These have a lumpy / bumpy appearance
(When no stalk is present, these are called sessile).
These Exostoses / Osteochondromas can cause numerous problems, including: compression of peripheral nerves or blood
vessels; irritation of tendons and muscles resulting in pain and loss of motion; skeletal deformity; short stature; limb length
discrepancy; chronic pain and fatigue; mobility issues; early onset arthritis; and an increased risk of developing malignant tumor
transformation (chondro-sarcoma) reported risk of 2%-5% over life time. It is not uncommon for MHE / MO / HME patients to
undergo numerous surgical procedures throughout their lives to remove painful or deforming Exostoses / Osteochondromas,
following these surgeries abnormal scarring can accrue with keloid formation. MHE / MO / HME patient also need to undergo
surgeries to correct the bone deformities as well as limb length discrepancies and improve range of motion. New scientific
findings are also showing autism relevant behavioral phenotype connected to MHE / MO / HME.
Surgery, physical therapy and pain management are currently the only options available to MHE / MO / HME patients, but their
success varies from patient to patient and many struggle with chronic pain, fatigue and mobility problems throughout their lives.
MHE / MO / HME is a genetic autosomal dominant hereditary disorder affecting 1/50, 000 people. This means that a patient with
MHE / MO / MHE has a 50% chance of transmitting this disorder to his / her children. Approximately 10% -20% of individuals
with MHE / MO / HME have the condition as a result of a spontaneous mutation are thus the first person in their family to be
affected.
There are two known genes found to cause MHE / MO / HME they are EXT1 located on chromosome 8q23-q24 and EXT2 located
on chromosome 11p11-p12. Approximately 60 to 70 % of mutations are located in the EXT1 gene and 20 to 30% are located in
the EXT2 gene. In 10 to 20% of the patients, no mutation is found.
long bones, growth plates or from the surface of flat bones throughout the body. The severity of this disease varies widely.
Some patients may have as few as two tumors, but most patients develop many more and the numbers of tumors can run into
the hundreds.
These cartilage-capped bone tumors are called Exostoses / Osteochondroma and may be sessile or pedunculated and vary
widely in size and shape. Pedunculated Exostoses / Osteochondroma is when a stalk is present, the structure is called
pedunculated. These have a Broccoli like appearance with stalk and growth towards the end of the stalk. Sessile Exostoses /
Osteochondroma have a broad-base attachment to the outer bone, called the "cortex". These have a lumpy / bumpy appearance
(When no stalk is present, these are called sessile).
These Exostoses / Osteochondromas can cause numerous problems, including: compression of peripheral nerves or blood
vessels; irritation of tendons and muscles resulting in pain and loss of motion; skeletal deformity; short stature; limb length
discrepancy; chronic pain and fatigue; mobility issues; early onset arthritis; and an increased risk of developing malignant tumor
transformation (chondro-sarcoma) reported risk of 2%-5% over life time. It is not uncommon for MHE / MO / HME patients to
undergo numerous surgical procedures throughout their lives to remove painful or deforming Exostoses / Osteochondromas,
following these surgeries abnormal scarring can accrue with keloid formation. MHE / MO / HME patient also need to undergo
surgeries to correct the bone deformities as well as limb length discrepancies and improve range of motion. New scientific
findings are also showing autism relevant behavioral phenotype connected to MHE / MO / HME.
Surgery, physical therapy and pain management are currently the only options available to MHE / MO / HME patients, but their
success varies from patient to patient and many struggle with chronic pain, fatigue and mobility problems throughout their lives.
MHE / MO / HME is a genetic autosomal dominant hereditary disorder affecting 1/50, 000 people. This means that a patient with
MHE / MO / MHE has a 50% chance of transmitting this disorder to his / her children. Approximately 10% -20% of individuals
with MHE / MO / HME have the condition as a result of a spontaneous mutation are thus the first person in their family to be
affected.
There are two known genes found to cause MHE / MO / HME they are EXT1 located on chromosome 8q23-q24 and EXT2 located
on chromosome 11p11-p12. Approximately 60 to 70 % of mutations are located in the EXT1 gene and 20 to 30% are located in
the EXT2 gene. In 10 to 20% of the patients, no mutation is found.
| The MHE Research Foundation Partnering in Advocacy and Education with the Musculoskeletal Tumor Society (MSTS) |
| Dr. Richard Lackman 2011 President of MSTS and long time supporter. Dr. Lackman is Porfessor and Director, Sarcoma Center of Excellence at the Abramson Cancer Center of the University of Pennsylvania |
| Dr. Lor Randal 2011 President of CTOS with Sarah Ziegler and Dr. Kevin Jones.Both are members of the Foundations advisory board. |
| Dr. Kevin B. Jones has authored the book "What Doctors Cannot Tell You: Clarity, Confidence and Uncertainty in Medicine" published June of 2012 Dr. Jones serves on the Scientific and Medical Advisory Board of our Foundation. We would like to thank Dr. Jones for all of his efforts on behalf of patients. |
| MHE Research was presented by Maurizio Pacifici, Ph.D., Director of Research, Division of Orthopaedic Surgery, The Children’s Hospital of Philadelphia and Sarah Ziegler in panel discussion. To view all video presentations from the 2013 Click Here To view the 2012 Symposium with Dr. Yu Yamaguchi's video presentation and all the others during this symposium Click Here |
Show your support for the MHE Research Foundation by wearing an MHE Bracelet designed by
Vincent (an 18 old who was born with MHE and has had over 25 surgeries to date) 100% of the
proceeds goes towards finding a cure for MHE. The cost is $ 5.00 each and can be ordered by
contacting Susan Eaton at mhefuntasia@gmail.com
Thanks a Bunch
Vincent (an 18 old who was born with MHE and has had over 25 surgeries to date) 100% of the
proceeds goes towards finding a cure for MHE. The cost is $ 5.00 each and can be ordered by
contacting Susan Eaton at mhefuntasia@gmail.com
Thanks a Bunch
| Opening remarks from Sarah Ziegler Foundation Vice President during the 2012 MHE Research Conference |
| Opening remarks from Craig Eaton Foundation President during the 2012 MHE Research Conference |
| The MHE Research Foundation Marjorie (Max) Reynolds Patient/Family Care Coordinator. |
If you are in the need of obtaining an Orthopaedic Surgeon and family support, please feel free to contact Max at anytime at
maxreynoldsmhe@gmail.com . As part of Max new role within the Foundation she is Director of the MHE / MO / HME Google support group
and Facebook etc and is assistant to Vice President Sarah Zieglerat sarahziegler@mheresearchfoundation.org
as Coordinator Clinical and Research Information.
maxreynoldsmhe@gmail.com . As part of Max new role within the Foundation she is Director of the MHE / MO / HME Google support group
and Facebook etc and is assistant to Vice President Sarah Zieglerat sarahziegler@mheresearchfoundation.org
as Coordinator Clinical and Research Information.
Our Foundations Vice President and National Director of Research Sarah Ziegler always will attend and have an educational
display at the Pediatric Orthopaedic Society of North America (POSNA) at annual conference to be held in April 30, 2014 – May 3,
2014 in Hollywood, California
display at the Pediatric Orthopaedic Society of North America (POSNA) at annual conference to be held in April 30, 2014 – May 3,
2014 in Hollywood, California
| Dr. George H. Thompson, POSNA 2003 President, POSNA 2011 President, Dr. James Roach, POSNA 2010 President, John P. Dormans and Sarah Ziegler |
| Dr. Charles T. Price, Distinguished Achievement Award and POSNA 2005 President Sarah Ziegler |
| Dr. James Roach POSNA 2011 President, Sarah Ziegler |
| Dr. Leon Root Dr. John P. Dormans Dr. Richard Davidson Dr. James McCarthy LLRS 2012 Dr. James Roach, Dr. Harold JP van Bosse |
| Dr. Benjamin A. Alman |
| Our Foundation would like to thank EPOS 2014 and participants especially Luca Sangiorgi, MD. Ph.D who is a foundation member of our Scientific and Medical Board Our Foundations Vice President and National Director of Research Sarah Ziegler held an educational display at the European Peadiatric Orthopaedic Society annual congress April 17-20, 2013 in Athens Greece. This meeting attracts Pediatric Orthopaedic surgeons from over 32 countries. During this conference. Dr. Dror Paley presented "Treatment of the Hip in Multiple Hereditary Exostoses (MHE) by Safe Surgical Dislocation " |
Full Day Workshop Summary: To date, nearly 500 unique rare bone diseases have been described, which in the aggregate
affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects
individuals throughout their lives. Currently, the vast majority of these disorders have no cure, yet studying rare bone diseases
has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with
common bone diseases too.
This workshop, coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient
Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and
Joint Initiative (USBJI) aims to:
1) Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to
advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for
individuals with both common and rare bone diseases;
2) Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective
research strategies in translational and therapeutic areas;
3) Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing
funding for a significant number of young investigators to attend; and
4) Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal.
The one-day workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and
encourage future research partnerships.
Click here to view agenda. Important to research professionals: To have your abstract considered for a poster
presentation at the National Bone Health Alliance/Rare Bone Disease Patient Network Workshop: Mechanistic and Therapeutic
Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases, in addition to the ASBMR 2014 Annual Meeting
presentations, select the box indicating your willingness in the “Scientific Information” section of the ASBMR Abstract Center.
The Abstract Submission Deadline for the ASBMR 2014 Annual Meeting is Wednesday, April 9, 2014, 5:00 p.m., Eastern
Daylight Time (EDT). In addition Up to 20 Young Investigator Travel Grants of $500 each will be given to individuals who are
selected to present their abstract.
affect 1 in 5,000 live births, and comprise 5% of all birth defects. Typically the disability caused by these diseases affects
individuals throughout their lives. Currently, the vast majority of these disorders have no cure, yet studying rare bone diseases
has helped elucidate biological pathways and reveal valuable targets for drug discovery that are benefitting patients with
common bone diseases too.
This workshop, coordinated by the National Bone Health Alliance (NBHA) in partnership with the Rare Bone Disease Patient
Network and with the support of the American Society for Bone and Mineral Research (ASBMR) and the United States Bone and
Joint Initiative (USBJI) aims to:
1) Convene a multi-disciplinary group of experts including researchers, clinicians, and patients with rare bone diseases to
advance our understanding of skeletal biology and encourage the development of novel therapies to improve outcomes for
individuals with both common and rare bone diseases;
2) Identify gaps in our knowledge regarding the biologic mechanisms underlying rare bone disorders and share effective
research strategies in translational and therapeutic areas;
3) Encourage broad participation both by holding the event the day before the ASBMR 2014 Annual Meeting and providing
funding for a significant number of young investigators to attend; and
4) Disseminate the results broadly by publishing the proceedings of the program in a peer-reviewed journal.
The one-day workshop will include lectures by invited speakers, and multiple opportunities to initiate collaborations and
encourage future research partnerships.
Click here to view agenda. Important to research professionals: To have your abstract considered for a poster
presentation at the National Bone Health Alliance/Rare Bone Disease Patient Network Workshop: Mechanistic and Therapeutic
Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases, in addition to the ASBMR 2014 Annual Meeting
presentations, select the box indicating your willingness in the “Scientific Information” section of the ASBMR Abstract Center.
The Abstract Submission Deadline for the ASBMR 2014 Annual Meeting is Wednesday, April 9, 2014, 5:00 p.m., Eastern
Daylight Time (EDT). In addition Up to 20 Young Investigator Travel Grants of $500 each will be given to individuals who are
selected to present their abstract.
| The 10 Annual International Pediatric Orthopaedic Symposium (IPOS) was held December 4-7 2013 presented by POSNA and AAOS and Dr. Dror Paley presented Treating MHE of the Proximal Femur and Dr. Pater Waters presented MHE and the forearm The 11 Annual International Pediatric Orthopaedic Symposium (IPOS) will be held Dec 3 - Dec 6, 2014 Our Foundations Vice President and National Director of Research Sarah Ziegler always will attend and have an educational display The MHE Research Foundation would like to express its gratitude to POSNA, AAOS, the leadership of these Societies on behalf our foundation for their support in the improvement of the clinical care MHE patients receive through all of the continuing educational efforts. As |
| Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases Thursday, September 11th, 2014 One day prior to the American Society for Bone and Mineral Research (ASBMR) 2014 Annual Meeting) George R. Brown Convention Center, 1001 Avenida De Las Americas, Houston, TX |
| The 4th International MHE Research Conference was held Nov 1- 4, 2012 to review the videos and download the conference abstract book Click Here and also Feb 2014 conference report Published in the Journal of Connective Tissue Research |
| Was held SUNDAY, SEPTEMBER 22, 2013 at El Caribe Country Club 2013 MHE Research Foundation "The Humanitarian Scientific Achievement Award" Presented to Dror Paley, MD, FRCSC Director Paley Advanced Limb Lengthening Institute Click Here to read more |
